Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs NextMeds

boostAGErx
Graded #183

Higher grade

vs+0.7000000000000028
NextMeds
Graded #208

Lower grade

The verdict

boostAGErx takes it — 66.8/100 to 66.1/100, but only just.

boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth brand offering compounded GLP-1 weight management (semaglutide and tirzepatide) starting around $95/mo on a 12-month upfront plan, plus peptide therapy such as… NextMeds is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +19
74
55
Dose & formulationboostAGErx +13
77
64
Clinical oversightNextMeds +3
74
77
Labs & monitoringNextMeds +9
52
61
FulfillmentNextMeds +15
69
84
Contract termsNextMeds +36
25
61
boostAGErx · left barNextMeds · right bar

The numbers

MetricboostAGErxNextMeds
WeighScore66.8/10066.1/100
GradeCC
Scorecard rank#183#208
Semaglutide$95/mo (starting dose, compounded)$129/mo (plus a separate fee, compounded)
Tirzepatide$95/mo (starting dose, compounded)$179/mo (plus a separate fee, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #183 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
  • Compounded medications are non-refundable once dispensed
  • Pharmacy partner not named on the site
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
NextMeds

Graded #208 · C

Strengths

  • Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
  • Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
  • Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
  • Free, no-obligation online assessment before you pay anything

Where it loses points

  • Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
  • Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
  • A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard